Botulinum toxin (BTX) therapy can temporarily improve gait in spastic paraparesis patients by reducing adductor muscle hypertonicity. However, transient effects suggest compensatory mechanisms limit long-term benefits.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: